1921-2021, from insulin to new hypoglycaemic drugs: 100 years of pharmacological research in diabetes mellitus.

Therapie

Service de pharmacologie médicale et clinique, centre de pharmacovigilance, pharmacoépidémiologie et d'informations sur le médicament, faculté de médecine, centre hospitalier universitaire, 37, allées Jules-Guesde, 31000 Toulouse, France. Electronic address:

Published: February 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.therap.2021.09.002DOI Listing

Publication Analysis

Top Keywords

1921-2021 insulin
4
insulin hypoglycaemic
4
hypoglycaemic drugs
4
drugs 100
4
100 years
4
years pharmacological
4
pharmacological diabetes
4
diabetes mellitus
4
1921-2021
1
hypoglycaemic
1

Similar Publications

Nicolae Paulescu (1869-1930) was born in Bucharest in an aristocratic family. His education from childhood to maturity (Paris University of Medicine) was marked by illustrious professors, even pioneers of their field. After completing his medical and scientific education in Paris under his mentor, Etienne Lancereaux, considered the founder of modern physiology, he returned to Romania where he founded the first Department of Physiology at "Carol Davila" University of Medicine and Pharmacy.

View Article and Find Full Text PDF

1921-2021, from insulin to new hypoglycaemic drugs: 100 years of pharmacological research in diabetes mellitus.

Therapie

February 2022

Service de pharmacologie médicale et clinique, centre de pharmacovigilance, pharmacoépidémiologie et d'informations sur le médicament, faculté de médecine, centre hospitalier universitaire, 37, allées Jules-Guesde, 31000 Toulouse, France. Electronic address:

View Article and Find Full Text PDF

1921-2021: From insulin discovery to islet transplantation in type 1 diabetes.

Ann Endocrinol (Paris)

April 2021

INSERM U1190, 59000 Lille, France; University of Lille, 59000 Lille, France; CHU Lille, Endocrinology, Diabetology, Metabolism, and Nutrition, 59000 Lille, France. Electronic address:

One century after the discovery of insulin, the French Health regulations have just authorized the reimbursement for islet transplantation. Intraportal islet allotransplantation from a pancreatic donor is indicated in patients with type 1 diabetes (T1D) complicated with lability or hypoglycemia unawareness, or in case of a functioning kidney graft; islet auto-transplantation may be indicated after pancreatic surgery.Compared with insulin even administered in closed-loop pumps, the specificity of islet allotransplantation is the restoration of C-peptide secretion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!